Health Care: Drugs

Teva Pharmaceutical Industries Ltd (TEVA: NYSE)

$35.2 n/a | n/a%
02/17/17 - 04:01 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 21.90B 19.65B 20.27B 20.31B
Cost of Sales 8.52B 6.99B 7.71B 7.96B
Gross Operating Profit 13.38B 12.66B 12.56B 12.35B
Selling, General, and Administrative Expenses 5.10B 4.72B 5.08B 6.84B
Research & Development 2.11B 1.52B 1.49B 1.43B
Operating Income before D & A (EBITDA) 6.18B 6.42B 6.00B 4.08B
Depreciation & Amortization 1.52B 1.31B 1.51B 1.64B
Interest Income 0.00 0.00 0.00 399.00M
Other Income - Net -1.04B -1.07B -31.00M -838.00M
Special Income / Charges -1.99B -1.36B -280.00M -788.00M
Total Income Before Interest Expenses (EBIT) 1.38B 2.50B 3.93B 1.21B
Interest Expense 546.00M 270.00M 300.00M 0.00
Pre-Tax Income 832.00M 2.23B 3.63B 1.21B
Income Taxes 521.00M 634.00M 591.00M -43.00M
Minority Interest -18.00M 9.00M -13.00M -16.00M
Net Income From Continuing Operations 311.00M 1.60B 3.04B 1.25B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 311.00M 1.60B 3.04B 1.25B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 329.00M 1.59B 3.06B 1.27B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.55B 3.14B 3.57B 2.04B
Preferred Dividends
Net Income Available To Common 50.00M 1.58B 3.04B 1.25B
Basic EPS from Continuing Ops. 0.07 1.84 3.58 1.49
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.07 1.84 3.58 1.49
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.07 1.84 3.58 1.49
Basic Normalized Net Income/Share 0.57 3.62 4.20 2.43
EPS fr Continuing Ops. 0.07 1.82 3.56 1.49
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.07 1.82 3.56 1.49
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.07 1.82 3.56 1.49
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.57 3.58 4.18 2.43
Dividends Paid per Share 1.36 1.36 1.37 1.28

Portfolios with TEVA

Latest TEVA Headlines from TheStreet

More Financial News for TEVA

Press Releases for TEVA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter